Powered by TWS IP AI Tool – Advanced IP & Market Intelligence Engine
RPI 2829 reveals a dynamic convergence of pharmaceutical trademarks, advanced patents, and health-tech software innovation in Brazil. TWS IP AI detected strategic filings by leading supplement brands, global pharma giants (Novartis, Roche), and a growing ecosystem of AI-enabled healthcare software. Sectors are merging—IP is becoming cross-functional, spanning therapy, tech, and consumer experience.
Pharma Patent Codes: A61K (preparations), A61P (indications), C07K/C12N (biotech/genetic).
Software Tags: AI (IA-01), Medical SD categories (SD-01 to SD-11), management platforms (GI-01).
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
These cookies are needed for adding comments on this website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com